Otherwise, the prevalence of severe AKI (KDIGO stage 2 and 3) was higher in the patients with [TIMP-2]∙[IGFBP7] > 0.3 (ng/ml)2/1000) (p = 0.026) (Supplementary Table 1S). The gene discussed is IGFBP7; the disease is acute kidney injury.